Clinical Trial Update: Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety and efficacy of collagenase Clostridium histolyticum for Peyronie's disease after prior intralesional PRP; recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

Sponsor: University of Miami | Conditions: Peyronie Disease, Sexual Dysfunctions, Psychological | Phase 4 | Status: RECRUITING